122 related articles for article (PubMed ID: 6228936)
1. [Methodology of a controlled trial of dihydroergotoxine in acquired intellectual impairment in the adult].
Dartigues JF; Père JJ
Presse Med; 1983 Dec; 12(48):3173-5. PubMed ID: 6228936
[TBL] [Abstract][Full Text] [Related]
2. The treatment of senile dementia associated with cerebrovascular insufficiency: a comparative study of buflomedil and dihydrogenated ergot alkaloids.
Jansen W; Bruckner GW; Jansen P
J Int Med Res; 1985; 13(1):48-53. PubMed ID: 3884411
[TBL] [Abstract][Full Text] [Related]
3. [Drug therapy of disorders of cerebral performance. Randomized comparative study of dihydroergotoxine and Ginkgo biloba extract].
Gerhardt G; Rogalla K; Jaeger J
Fortschr Med; 1990 Jun; 108(19):384-8. PubMed ID: 2199358
[TBL] [Abstract][Full Text] [Related]
4. [Dihydroergotoxine mesylate in the treatment of senile cerebral insufficiency. Result of a long-term multicenter double-blind clinical trial with a placebo].
Lazzari R; Passeri M; Chierichetti SM
Presse Med; 1983 Dec; 12(48):3179-85. PubMed ID: 6228938
[TBL] [Abstract][Full Text] [Related]
5. [A multicenter trial of treatment with slow-release dihydroergotoxine in chronic senile cerebral insufficiency].
Franchi F; Di Ruvo R; Guggino G; Mazzanti A; Genga A; Cucinotta D
G Clin Med; 1982 Jul; 63(7):465-81. PubMed ID: 6757035
[No Abstract] [Full Text] [Related]
6. Deapril-ST for senile dementia.
Med Lett Drugs Ther; 1977 Jul; 19(15):61-2. PubMed ID: 327247
[No Abstract] [Full Text] [Related]
7. [Comparison of dihydroergotoxine and placebo in the treatment of moderate arterial hypertension in older persons].
Bagatin J; Rumboldt Z; Jurisić M; Vujić D
Med Pregl; 1988; 41(1-2):74-7. PubMed ID: 3054457
[No Abstract] [Full Text] [Related]
8. The clinical assessment of brain failure in the elderly.
McConnachie RW
Pharmacology; 1978; 16 Suppl 1():27-35. PubMed ID: 347464
[TBL] [Abstract][Full Text] [Related]
9. Controlled study of dihydroergotoxine in gerontopsychiatric patients.
Slánská J
Act Nerv Super (Praha); 1989 Apr; 31(1):53-5. PubMed ID: 2782002
[No Abstract] [Full Text] [Related]
10. [Comparison of subjective tolerance of hydergine specific and hydergine in gerontologic therapy].
Ronge J; Dennler HJ
Med Welt; 1982 Oct; 33(42):1485-9. PubMed ID: 6757638
[No Abstract] [Full Text] [Related]
11. [Controlled clinical trial of dihydroergocristine in neuropsychiatric disorders in cerebrovascular insufficiency].
Muchnik S
Boll Chim Farm; 1982 May; 121(5):33S-46S. PubMed ID: 6814466
[No Abstract] [Full Text] [Related]
12. [Controlled clinical study of use of dihydroergocristine in cerebral and periferal vascular disorders].
Calisti G; Biscarini L; Miseo A
Clin Ter; 1977 Nov; 83(4):371-86. PubMed ID: 414875
[No Abstract] [Full Text] [Related]
13. Double-blind clinical and psychologic study of ergoloid mesylates (Hydergine) in subjects with senile mental deterioration.
van Loveren-Huyben CM; Engelaar HF; Hermans MB; van der Bom JA; Leering C; Munnichs JM
J Am Geriatr Soc; 1984 Aug; 32(8):584-8. PubMed ID: 6379022
[TBL] [Abstract][Full Text] [Related]
14. Effects of intravenous high dose co-dergocrine mesylate ('Hydergine') in elderly patients with severe multi-infarct dementia: a double-blind, placebo-controlled trial.
Arrigo A; Casale R; Giorgi I; Guarnaschelli C; Zelaschi F
Curr Med Res Opin; 1989; 11(8):491-500. PubMed ID: 2680286
[TBL] [Abstract][Full Text] [Related]
15. A controlled double-blind study of high-dose dihydroergotoxine mesylate (Hydergine) in mild dementia.
Thienhaus OJ; Wheeler BG; Simon S; Zemlan FP; Hartford JT
J Am Geriatr Soc; 1987 Mar; 35(3):219-23. PubMed ID: 3819261
[TBL] [Abstract][Full Text] [Related]
16. Electroencephalographic and clinical changes as correlated in geriatric patients treated three months with an ergot alkaloid preparation.
Matejcek M; Knor K; Piguet PV; Weil C
J Am Geriatr Soc; 1979 May; 27(5):198-202. PubMed ID: 372291
[TBL] [Abstract][Full Text] [Related]
17. Dihydroergotoxine: 6-mg versus 3-mg dosage in the treatment of senile dementia. Preliminary report.
Yesavage JA; Hollister LE; Burian E
J Am Geriatr Soc; 1979 Feb; 27(2):80-2. PubMed ID: 762369
[TBL] [Abstract][Full Text] [Related]
18. [Critical approach to a therapeutic trial in secondary prevention of cerebral ischemic accidents by antiaggregants].
Guiraud-Chaumeil B
Presse Med; 1983 Dec; 12(48):3045-8. PubMed ID: 6228912
[No Abstract] [Full Text] [Related]
19. [Dihydroergocristine in organic brain psychosyndrome. Multicenter placebo-controlled clinical double-blind study in 240 patients].
Lazzaroni M; Cattalini C; Massetto N; Poli A
Arzneimittelforschung; 1992 Nov; 42(11A):1410-3. PubMed ID: 1492864
[TBL] [Abstract][Full Text] [Related]
20. [Hydergin therapy of cerebrovascular insufficiency in patients requiring digitalis. Results of a double-blind study (author's transl)].
Dennler HJ; Bachmann H
MMW Munch Med Wochenschr; 1979 Nov; 121(48):1615-8. PubMed ID: 118360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
